American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Secondhand Nicotine Absorption From E-Cigarette Vapor vs Tobacco Smoke in Children
Lead: Secondhand Nicotine Absorption From E-Cigarette Vapor vs Tobacco Smoke in Children
Lead: Secondhand Nicotine Absorption From E-Cigarette Vapor vs Tobacco Smoke in Children
Tuesday 23rd July 2024
Explore how secondhand nicotine exposure from e-cigarettes compares to tobacco smoke in children, along with insights on opioid treatments and telehealth stigma.
5 minutes
Informative
Educational
Eye-opening
Compassionate
Supportive
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
144 (View all)
Do you want to link to this podcast?
Get the buttons here!Comparing Secondhand Nicotine Exposure in Children: Smoke vs. Vapor
Episode Overview
- Children absorb significantly less nicotine from secondhand e-cigarette vapor compared to tobacco smoke.
- Seven-day extended-release buprenorphine shows promise for treating mild opioid withdrawal.
- Acupuncture may help reduce methadone doses and manage opioid cravings.
- Telehealth can both alleviate and exacerbate stigma in opioid use disorder treatment.
- New biosensor techniques offer insights into opioid neuropeptide dynamics.
Switching from smoking to vaping indoors may substantially reduce children's second-hand exposure to nicotine and other noxious substances
Ever wondered how secondhand nicotine exposure from e-cigarettes stacks up against traditional tobacco smoke for children? This episode of 'This Week in Addiction Medicine from ASAM' dives into a fascinating study that compares the nicotine absorption levels in kids exposed to secondhand smoke versus e-cigarette vapor. You'll learn that children exposed to secondhand vapor absorb significantly less nicotine compared to those exposed to tobacco smoke.
The discussion also touches on the implications of these findings, suggesting that switching from smoking to vaping indoors might reduce children's exposure to harmful substances, although both are still more harmful than no exposure at all. The episode doesn't stop there. It covers an intriguing study on the feasibility of a seven-day extended-release buprenorphine injection for patients with mild opioid withdrawal symptoms.
The results indicate a promising future for this treatment method, potentially increasing the number of patients receiving buprenorphine induction. Additionally, the episode explores the potential benefits of acupuncture in helping patients reduce their methadone doses and manage opioid cravings. This segment highlights the positive outcomes from an eight-week trial but also notes the need for longer-term studies. A qualitative analysis of stigma experienced by patients using telehealth for opioid use disorder treatment is another key topic.
The mixed results reveal that while telehealth can reduce internalised stigma and increase clinician trust, it also has its own set of challenges, particularly concerning privacy at home. Lastly, you'll hear about groundbreaking research using genetically encoded biosensors to study opioid neuropeptide dynamics. This innovative technique could pave the way for better understanding pain, stress, reward, and addiction mechanisms.
With a range of studies and expert insights, this episode offers a comprehensive look at current issues and advancements in addiction medicine. Don't miss out on these eye-opening discussions that could change how we approach addiction treatment and prevention.